Promimic Named as One of Sweden's Hottest Technology Companies

Promimic Named as One of Sweden's Hottest Technology Companies

ID: 52997

(Thomson Reuters ONE) -


Stockholm, Sweden - March 31, 2011, Promimic, 25 percent owned by Karolinska
Development, has been chosen by the papers Affärsvärlden och Ny Teknik as one of
Sweden's 33 Hottest Young technology companies for 2011. Promimic has been
chosen for the company's nano-thin synthetic bone surface, which is considered
to be unique and to have a large international market potential.

This year has been tougher than ever to get into 33-list. Over 200 companies
were nominated, and many of them were present at the award ceremony and dinner
held at Berns Salonger in Stockholm last night.

"We are very pleased to be on the list, says Ulf Brogren, CEO of Promimic. So
far during 2011 we have had time to complete a new share issue and get approval
from FDA for our implant surface. Now to be one of the 33 hottest technology
companies in Sweden feels like an exciting continuation of the year.

The country's 33 hottest technology companies, appointed each year by the
editorial staff of the Affärsvärlden and Ny Teknik is based on their overall
assessment of companies' innovation and business potential. In addition, the
company must be based in Sweden, be less than seven years old and not listed on
a stock exchange.


For further information, please contact:
Ulf Brogren, CEO Promimic
Phone: +46 (0) 31-772 80 22, e-mail:ulf.brogren(at)promimic.se


TO THE EDITORS


About Promimic
Promimic is a Gothenburg based company that develops and commercializes products
within the area of biomaterials. Promimic products, HANANO(TM) Surface, belong
to a new generation of implant surfaces. The nanometer-thin surface is based on
the substance hydroxyapatite (HA), which by size, shape, structure and chemistry
mimics the living bone tissue. The similarity with human bone facilitates the
integration of the implants. Since the HANANO(TM) Surface can be applied as an




extremely thin layer (20 nanometers) it will effectively covers all parts of the
implant surface, even on highly porous implant materials.


About Karolinska Development
Karolinska Development aims to create value for investors, patients, and
researchers by developing innovations from world class research into products
that can be sold or out-licensed with high returns. The business model is to:
SELECT the most commercially attractive medical innovations; DEVELOP these to
the stage where the greatest return on investment can be achieved; and
COMMERCIALIZE the innovations through the sale of companies or out licensing of
products. This will result in upfront payments, milestone payments and
royalties.

An exclusive deal flow agreement with Karolinska Institutet Innovations AB,
along with other cooperation agreements with leading Nordic universities,
delivers a continuous flow of innovations.

Karolinska Development's flexible exit strategy enables projects to be exited at
whichever stage of development offers the greatest return on investment, usually
after Phase II clinical trials have indicated the desired pharmaceutical effect
on patients - this being an important value enhancing step.

Today, the portfolio consists of over 40 projects at various stages, from
concept development to Phase II clinical trials, twelve projects are in clinical
trials with six in Phase II. The portfolio is particularly strong in the areas
of cancer, dermatology, inflammation, cardiovascular disease, women's health and
diseases that affect the central nervous system. www.karolinskadevelopment.com




Read Press Release as PDF:
http://hugin.info/143071/R/1501815/437130.pdf




This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Karolinska Development AB (publ) via Thomson Reuters ONE

[HUG#1501815]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Number of A and B shares in Ratos NONG - Bonus issue and split registered in the Norwegian Register of Business Enterprises
Bereitgestellt von Benutzer: hugin
Datum: 31.03.2011 - 08:55 Uhr
Sprache: Deutsch
News-ID 52997
Anzahl Zeichen: 4542

contact information:
Town:

Solna



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 208 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Promimic Named as One of Sweden's Hottest Technology Companies"
steht unter der journalistisch-redaktionellen Verantwortung von

Karolinska Development AB (publ) (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Karolinska Development AB (publ)



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z